Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments

from Mission Matters Business Podcast with Adam Torres · host Adam Torres

Quantum BioPharma is developing a portfolio of products including Quantum's Lucid-MS drug development and their drink, unbuzzd. In this episode, Adam Torres and Jason Sawyer, Head of Finance & M&A at Quantum BioPharma, explore Quantum BioPharma. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Jan 30, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments

0:00 18:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Mission Matters Business Podcast with Adam Torres?

This episode is 18 minutes long.

When was this Mission Matters Business Podcast with Adam Torres episode published?

This episode was published on January 30, 2025.

Can I download this Mission Matters Business Podcast with Adam Torres episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!